MARVELD2; DFNB49; MARVD2; MRVLDC2; MARVEL Domain Containing Protein 2; Deafness,Autosomal Recessive 49
MARVELD2; DFNB49; MARVD2; MRVLDC2; MARVEL Domain Containing Protein 2; Deafness,Autosomal Recessive 49
CSE; Cystathionase; Cysteine-protein sulfhydrase; Gamma-cystathionase
CSE; Cystathionase; Cysteine-protein sulfhydrase; Gamma-cystathionase
GIG13; Cell growth-inhibiting gene 13 protein; Circadian clock protein PERIOD 3
GIG13; Cell growth-inhibiting gene 13 protein; Circadian clock protein PERIOD 3
SDC2; HSPG1; SYND2; Fibroglycan; Syndecan 2; Syndecan Proteoglycan 2; Heparan Sulfate Proteoglycan 1,Cell Surface-Associated; Heparan Sulphate Proteoglycan
SDC2; HSPG1; SYND2; Fibroglycan; Syndecan 2; Syndecan Proteoglycan 2; Heparan Sulfate Proteoglycan 1,Cell Surface-Associated; Heparan Sulphate Proteoglycan
C-SAA; CSAA; SA-A4; Constitutively expressed serum amyloid A protein
C-SAA; CSAA; SA-A4; Constitutively expressed serum amyloid A protein
AM; PAMP; Proadrenomedullin N-20 terminal peptide; ProAM N-terminal 20 peptide
AM; PAMP; Proadrenomedullin N-20 terminal peptide; ProAM N-terminal 20 peptide